Brady Johnson - 09 Jul 2021 Form 3 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Signature
/s/ Brady Johnson
Issuer symbol
CDTX
Transactions as of
09 Jul 2021
Net transactions value
$0
Form type
3
Filing time
19 Jul 2021, 14:55:08 UTC
Next filing
30 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CDTX Common Stock 26,369 09 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CDTX Stock Option (right to buy) 09 Jul 2021 Common Stock 12,111 $2.45 Direct F1
holding CDTX Stock Option (right to buy) 09 Jul 2021 Common Stock 20,012 $2.45 Direct F2
holding CDTX Stock Option (right to buy) 09 Jul 2021 Common Stock 6,700 $1.98 Direct F3
holding CDTX Stock Option (right to buy) 09 Jul 2021 Common Stock 12,150 $2.55 Direct F4
holding CDTX Restricted Stock Unit 09 Jul 2021 Common Stock 524 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third (1/3) of the shares subject to the option vested on December 18, 2020 and the remainder vests and becomes exercisable in a series of twenty-four (24) successive equal monthly installments thereafter until fully vested on December 18, 2022.
F2 Shares are fully vested
F3 The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 19, 2020.
F4 The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 17, 2021.
F5 The shares shall vest upon the achievement of various clinical and corporate milestones.
F6 Restricted stock units convert into common stock on a one-for-one basis.